NCT03000023View on ClinicalTrials.gov

Anticipated and Perceived Benefits Following Hepatitis C Treatment

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Hepatitis CHepatitis C, Chronic

Trial Locations (1)

27599

University of North Carolina, Chapel Hill

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER